ranbaxy laboratories

Advertisement
Forbes List Logo
Sun Pharma's shares fall by 15% after 'negative surprise'
India's largest generics drugs maker informs bourses that consolidated profitability of the company may be adversely affected in FY16
ByAveek Datta
Sun Pharma sees 70% increase in revenues in FY15
ByShabana Hussain
Sun Has a Better Shot Than Most at Ranbaxy Turnaround
ByPriyanka Pulla
Daiichi could be the biggest beneficiary of the Sun Pharma-Ranbaxy deal
BySalil Panchal
Dr. Reddy’s Rejuvenation
ByT Surendar
Advertisement
  • Home
    • /
  • Ranbaxy-laboratories

Latest News

Forbes List Logo
What makes U.S. multinationals shift costs back home to save on taxes
ByStanford
Trade And Business Trends: What to expect in 2026
ByForbes India
The woman who's breaking barriers by design
ByBenu Joshi Routh
A personal tutor for all
ByNaini Thaker
India’s FY26 GDP growth pegged at 7.4% in first advance estimates
ByVasudha Mukherjee
How attention economy is re-shaping marketing
ByInternational Management Institute (Delhi)
Advertisement
Advertisement
Advertisement